Unfinished business: ending the HIV epidemic
SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to…
Becton, Dickinson and Company (BDX)
Provides Preliminary Revenue for Fourth Quarter and Full Year Fiscal 2025 FRANKLIN LAKES, N.J., Oct. 15, 2025 /PRNewswire/…
Focused sound energy holds promise for treating cancer, Alzheimer’s and other diseases
Sound waves at frequencies above the threshold for human hearing are routinely used in medical care. Also known…
An AI system goes head-to-head with a human expert to work through a challenging medical case
Overview of CPC-Bench and Dr. CaBot. Credit: arXiv (2025). DOI: 10.48550/arxiv.2509.12194 Except for one key aspect, the setup…
Medicine’s Transcendental Meaning, and How to Eat an Elephant
The first week of September found me at the Catholic Medical Association’s annual conference in Kansas City. The…
Why Jeremy Clarkson changed his mind about the NHS | World News
For a man who’s made a career out of roaring engines and roaring opinions, Jeremy Clarkson has always…
Town Hall Ventures Announces $440 Million Fund IV to Advance AI and Healthcare Innovation for Underserved Communities
Expanded Leadership Team Announced NEW YORK, Oct. 15, 2025 /PRNewswire/ — Town Hall Ventures announced today that it…
Calvary Health Care questioned over Launceston private hospital’s future after infrastructure failure
A major infrastructure failure at a private hospital in Tasmania’s north has healthcare experts calling for assurances about…
We’re downgrading it, considering next move
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue…
Who’s to blame for the NHS’s blame culture? | NHS
Jeremy Hunt’s article (Here’s the direct effect of our NHS blame culture: babies die. Tragedy after tragedy, it…
Siemens AG Considers Spin-Off Of Siemens Healthineers Stake
(Photo by Matthias Balk/picture alliance via Getty Images) dpa/picture alliance via Getty Images Deal OverviewOn October 2, 2025,…
Novo Nordisk and Omeros announce asset purchase and license
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease…